These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9516956)

  • 21. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
    Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
    Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estramustine on DNA and cell membrane in malignant glioma cells.
    von Schoultz E; Grankvist K; Gustavsson H; Henriksson R
    Acta Oncol; 1991; 30(6):719-23. PubMed ID: 1958392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The experimental research of the rhBMP-2-induced apoptosis in human glioma cells].
    Zhang X; Wu J; Jing J
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):610-3. PubMed ID: 11798828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells.
    Cavalieri E; Mariotto S; Fabrizi C; de Prati AC; Gottardo R; Leone S; Berra LV; Lauro GM; Ciampa AR; Suzuki H
    Biochem Biophys Res Commun; 2004 Mar; 315(3):589-94. PubMed ID: 14975741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines.
    Serafin AM; Bohm L
    Urol Oncol; 2005; 23(2):123-9. PubMed ID: 15869997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of estramustine and its constituents on human malignant glioma cells.
    von Schoultz E; Lundgren E; Henriksson R
    Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
    Kelly WK; Zhu AX; Scher H; Curley T; Fallon M; Slovin S; Schwartz L; Larson S; Tong W; Hartley-Asp B; Pellizzoni C; Rocchetti M
    Clin Cancer Res; 2003 Jun; 9(6):2098-107. PubMed ID: 12796374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
    Fulda S; Wick W; Weller M; Debatin KM
    Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S; Weller M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.
    Uhm JH; Dooley NP; Kyritsis AP; Rao JS; Gladson CL
    Clin Cancer Res; 1999 Jun; 5(6):1587-94. PubMed ID: 10389948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    Kanzawa T; Zhang L; Xiao L; Germano IM; Kondo Y; Kondo S
    Oncogene; 2005 Feb; 24(6):980-91. PubMed ID: 15592527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
    Kanzawa T; Kondo Y; Ito H; Kondo S; Germano I
    Cancer Res; 2003 May; 63(9):2103-8. PubMed ID: 12727826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.
    Johansson M; Bergenheim AT; Widmark A; Henriksson R
    Br J Cancer; 1999 Apr; 80(1-2):142-8. PubMed ID: 10389990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.
    Behnam-Motlagh P; Jonsson O; Engström KG; Henriksson R; Grankvist K
    Br J Cancer; 1997; 76(3):318-24. PubMed ID: 9252198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.